These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20192187)

  • 1. A chiral wedge molecule inhibits telomerase activity.
    Shinohara K; Sannohe Y; Kaieda S; Tanaka K; Osuga H; Tahara H; Xu Y; Kawase T; Bando T; Sugiyama H
    J Am Chem Soc; 2010 Mar; 132(11):3778-82. PubMed ID: 20192187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recognition of higher-order G-quadruplex by chiral cyclic-helicene molecules.
    Xu Y; Yamazaki S; Osuga H; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2006; (50):183-4. PubMed ID: 17150878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
    Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
    Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
    Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA loop sequence as the determinant for chiral supramolecular compound G-quadruplex selectivity.
    Yu H; Zhao C; Chen Y; Fu M; Ren J; Qu X
    J Med Chem; 2010 Jan; 53(1):492-8. PubMed ID: 19911822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
    Moorhouse AD; Haider S; Gunaratnam M; Munnur D; Neidle S; Moses JE
    Mol Biosyst; 2008 Jun; 4(6):629-42. PubMed ID: 18493662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interactions with intra- and intermolecular G-quadruplex DNA structures by hydrosoluble coronene derivatives: a new class of telomerase inhibitors.
    Franceschin M; Alvino A; Casagrande V; Mauriello C; Pascucci E; Savino M; Ortaggi G; Bianco A
    Bioorg Med Chem; 2007 Feb; 15(4):1848-58. PubMed ID: 17150364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (P)-helicene displays chiral selection in binding to Z-DNA.
    Xu Y; Zhang YX; Sugiyama H; Umano T; Osuga H; Tanaka K
    J Am Chem Soc; 2004 Jun; 126(21):6566-7. PubMed ID: 15161280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isaindigotone derivatives: a new class of highly selective ligands for telomeric G-quadruplex DNA.
    Tan JH; Ou TM; Hou JQ; Lu YJ; Huang SL; Luo HB; Wu JY; Huang ZS; Wong KY; Gu LQ
    J Med Chem; 2009 May; 52(9):2825-35. PubMed ID: 19354252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
    Bhattacharya S; Chaudhuri P; Jain AK; Paul A
    Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells.
    Gunaratnam M; Neidle S
    Methods Mol Biol; 2010; 613():303-13. PubMed ID: 19997892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quadruplex DNA crystal structures and drug design.
    Neidle S; Parkinson GN
    Biochimie; 2008 Aug; 90(8):1184-96. PubMed ID: 18395014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.
    Alcaro S; Artese A; Costa G; Distinto S; Ortuso F; Parrotta L
    Biochimie; 2011 Aug; 93(8):1267-74. PubMed ID: 21699954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures.
    Garner TP; Williams HE; Gluszyk KI; Roe S; Oldham NJ; Stevens MF; Moses JE; Searle MS
    Org Biomol Chem; 2009 Oct; 7(20):4194-200. PubMed ID: 19795057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [G-quadruplex DNA: myth or reality?].
    Riou JF; Gomez D; Lemarteleur T; Trentesaux C
    Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
    Gomez D; Mergny JL; Riou JF
    Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.